Imperva (IMPV) versus Its Rivals Head to Head Analysis
Imperva (NYSE: IMPV) is one of 197 publicly-traded companies in the “IT Services & Consulting” industry, but how does it contrast to its competitors? We will compare Imperva to similar companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, earnings, valuation and profitability.
Valuation & Earnings
This table compares Imperva and its competitors gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Imperva||$293.55 million||-$18.92 million||-21.41|
|Imperva Competitors||$2.11 billion||$365.95 million||11.99|
Imperva’s competitors have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Institutional & Insider Ownership
92.7% of Imperva shares are held by institutional investors. Comparatively, 61.0% of shares of all “IT Services & Consulting” companies are held by institutional investors. 2.2% of Imperva shares are held by insiders. Comparatively, 17.0% of shares of all “IT Services & Consulting” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This table compares Imperva and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk and Volatility
Imperva has a beta of 2.23, meaning that its stock price is 123% more volatile than the S&P 500. Comparatively, Imperva’s competitors have a beta of 1.26, meaning that their average stock price is 26% more volatile than the S&P 500.
This is a breakdown of current recommendations and price targets for Imperva and its competitors, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Imperva presently has a consensus target price of $52.57, suggesting a potential upside of 19.20%. As a group, “IT Services & Consulting” companies have a potential upside of 2.53%. Given Imperva’s stronger consensus rating and higher possible upside, equities analysts plainly believe Imperva is more favorable than its competitors.
Imperva beats its competitors on 8 of the 12 factors compared.
Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.